Patrocinados
Osteogenesis Imperfecta Treatment Market Growth Supported by Rising NIH Grants and Clinical Trials
The global Osteogenesis Imperfecta Treatment Market was valued at US$ 750.2 million in 2024 and is projected to reach US$ 885.34 million by 2031, with a compound annual growth rate (CAGR) of 2.1% during the forecast period 2025-2031, according to DataM Intelligence. Osteogenesis Imperfecta (OI), or brittle bone disease, is a genetic disorder causing fragile bones prone to fractures, with at...
0 Commentarios 0 Acciones 455 Views 0 Vista previa
Patrocinados
Patrocinados
Patrocinados